Genetic determinants of acquired cholestasis: A systems biology approach

Frontiers in Bioscience

Volumn 17, Issue 1, 2012, Pages 206-220

  Sookoian, Silvia ^a   Pirola, Carlos Jose ^a  

^a INSTITUTO DE INVESTIGACIONES MÉDICAS ALFREDO LANARI   (Argentina)

Author keywords

Cholestatic disorders; Gene Prioritization; Integrative Genetics; Review; System Biology

Indexed keywords

EID: 84860275750     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3922     Document Type: Article

References (72)

1. M. M. Kaplan and M. E. Gershwin: Primary biliary cirrhosis. N Engl J Med 353, 1261-1273 (2005) (Pubitemid 41345948)
2. Y. M. Lee and M. M. Kaplan: Primary sclerosing cholangitis. N Engl J Med 332, 924-933 (1995)
3. B. Pathak, L. Sheibani and R. H. Lee: Cholestasis of pregnancy. Obstet Gynecol Clin North Am 37, 269-282 (2010)
4. K. Agarwal, D. E. Jones, A. K. Daly, O. F. James, B. Vaidya, S. Pearce and M. F. Bassendine: CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis. J Hepatol 32, 538-541 (2000) (Pubitemid 30180371)
5. B. D. Juran, E. J. Atkinson, E. M. Schlicht, B. L. Fridley and K. N. Lazaridis: Primary biliary cirrhosis is associated with a genetic variant in the 3' flanking region of the CTLA4 gene. Gastroenterology 135, 1200-1206 (2008)
6. L. Y. Fan, X. Q. Tu, Q. B. Cheng, Y. Zhu, R. Feltens, T. Pfeiffer and R. Q. Zhong: Cytotoxic T lymphocyte associated antigen-4 gene polymorphisms confer susceptibility to primary biliary cirrhosis and autoimmune hepatitis in Chinese population. World J Gastroenterol 10, 3056-3059 (2004) (Pubitemid 39303063)
7. S. Oertelt, T. P. Kenny, C. Selmi, P. Invernizzi, M. Podda and M. E. Gershwin: SNP analysis of genes implicated in T cell proliferation in primary biliary cirrhosis. Clin Dev Immunol 12, 259-263 (2005) (Pubitemid 43062434)
8. P. Donaldson, S. Veeramani, A. Baragiotta, A. Floreani, C. Venturi, S. Pearce, V. Wilson, D. Jones, O. James, J. Taylor, J. Newton and M. Bassendine: Cytotoxic T-lymphocyte-associated antigen-4 single nucleotide polymorphisms and haplotypes in primary biliary cirrhosis. Clin Gastroenterol Hepatol 5, 755-760 (2007) (Pubitemid 46830049)
9. P. L. Bittencourt, S. A. Palacios, E. L. Cancado, G. Porta, F. J. Carrilho, A. A. Laudanna, J. Kalil and A. C. Goldberg: Cytotoxic T lymphocyte antigen-4 gene polymorphisms do not confer susceptibility to autoimmune hepatitis types 1 and 2 in Brazil. Am J Gastroenterol 98, 1616-1620 (2003) (Pubitemid 36875357)
10. R. Eri, J. R. Jonsson, N. Pandeya, D. M. Purdie, A. D. Clouston, N. Martin, D. Duffy, E. E. Powell, J. Fawcett, T. H. Florin and G. L. Radford-Smith: CCR5-Delta32 mutation is strongly associated with primary sclerosing cholangitis. Genes Immun 5, 444-450 (2004) (Pubitemid 39276159)
11. L. Henckaerts, J. Fevery, S. W. Van, C. Verslype, P. Yap, F. Nevens, T. Roskams, L. Libbrecht, P. Rutgeerts and S. Vermeire: CCtype chemokine receptor 5-Delta32 mutation protects against primary sclerosing cholangitis. Inflamm Bowel Dis 12, 272-277 (2006)
12. E. Melum, T. H. Karlsen, U. Broome, E. Thorsby, E. Schrumpf, K. M. Boberg and B. A. Lie: The 32-base pair deletion of the chemokine receptor 5 gene (CCR5-Delta32) is not associated with primary sclerosing cholangitis in 363 Scandinavian patients. Tissue Antigens 68, 78-81 (2006) (Pubitemid 43892880)
13. P. J. Meier and B. Stieger: Bile salt transporters. Annu Rev Physiol 64, 635-661 (2002) (Pubitemid 34259244)
14. P. H. Dixon and C. Williamson: The molecular genetics of intrahepatic cholestasis of pregnancy. Obstet Med 1, 65-71 (2008)
15. T. H. Karlsen and J. R. Hov: Genetics of cholestatic liver disease in 2010. Curr Opin Gastroenterol 26, 251-258 (2010)
16. S. Sookoian, G. Castano, A. Burgueno, T. F. Gianotti and C. J. Pirola: Association of the multidrug-resistance-associated protein gene (ABCC2) variants with intrahepatic cholestasis of pregnancy. J Hepatol 48, 125-132 (2008) (Pubitemid 350191993)
17. A. Davit-Spraul, E. Gonzales, C. Baussan and E. Jacquemin: The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects. Semin Liver Dis 30, 134-146 (2010)
18. O. Rosmorduc, B. Hermelin and R. Poupon: MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis. Gastroenterology 120, 1459-1467 (2001) (Pubitemid 32322320)
19. A. S. Azmi, Z. Wang, P. A. Philip, R. M. Mohammad and F. H. Sarkar: Proof of concept: network and systems biology approaches aid in the discovery of potent anticancer drug combinations. Mol Cancer Ther 9, 3137-3144 (2010)
20. S. Sookoian and C. J. Pirola: Metabolic Syndrome: From the Genetics to the Pathophysiology. Curr Hypertens Rep (2010). Epub (DOI: 10.1007/s11906-010- 0164-9).
21. S. W. Van Mil, A. Milona, P. H. Dixon, R. Mullenbach, V. L. Geenes, J. Chambers, V. Shevchuk, G. E. Moore, F. Lammert, A. G. Glantz, L. A. Mattsson, J. Whittaker, M. G. Parker, R. White and C. Williamson: Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy. Gastroenterology 133, 507-516 (2007) (Pubitemid 47187340)
22. V. Zimmer, R. Mullenbach, E. Simon, C. Bartz, S. Matern and F. Lammert: Combined functional variants of hepatobiliary transporters and FXR aggravate intrahepatic cholestasis of pregnancy. Liver Int 29, 1286-1288 (2009)
23. L. Henckaerts, M. Jaspers, S. W. Van, L. Vliegen, J. Fevery, H. Nuytten, T. Roskams, P. Rutgeerts, J. J. Cassiman, S. Vermeire and H. Cuppens: Cystic fibrosis transmembrane conductance regulator gene polymorphisms in patients with primary sclerosing cholangitis. J Hepatol 50, 150-157 (2009)
24. P. Kovacs, R. Kress, J. Rocha, U. Kurtz, J. F. Miquel, F. Nervi, N. Mendez-Sanchez, M. Uribe, H. H. Bock, R. Schirin-Sokhan, M. Stumvoll, J. Mossner, F. Lammert and H. Wittenburg: Variation of the gene encoding the nuclear bile salt receptor FXR and gallstone susceptibility in mice and humans. J Hepatol 48, 116-124 (2008) (Pubitemid 350191984)
25. G. Castano, A. Burgueno, G. T. Fernandez, C. J. Pirola and S. Sookoian: The influence of common gene variants of the xenobiotic receptor (PXR) in genetic susceptibility to intrahepatic cholestasis of pregnancy. Aliment Pharmacol Ther 31, 583-592 (2010)
26. T. H. Karlsen, B. A. Lie, F. K. Frey, E. Thorsby, U. Broome, E. Schrumpf and K. M. Boberg: Polymorphisms in the steroid and xenobiotic receptor gene influence survival in primary sclerosing cholangitis. Gastroenterology 131, 781-787 (2006) (Pubitemid 44307062)
27. K. Wallace, D. E. Cowie, D. K. Konstantinou, S. J. Hill, T. E. Tjelle, A. Axon, M. Koruth, S. A. White, H. Carlsen, D. A. Mann and M. C. Wright: The PXR is a drug target for chronic inflammatory liver disease. J Steroid Biochem Mol Biol 120, 137-148 (2010)
28. T. H. Karlsen, A. Franke, E. Melum, A. Kaser, J. R. Hov, T. Balschun, B. A. Lie, A. Bergquist, C. Schramm, T. J. Weismuller, D. Gotthardt, C. Rust, E. E. Philipp, T. Fritz, L. Henckaerts, R. K. Weersma, P. Stokkers, C. Y. Ponsioen, C. Wijmenga, M. Sterneck, M. Nothnagel, J. Hampe, A. Teufel, H. Runz, P. Rosenstiel, A. Stiehl, S. Vermeire, U. Beuers, M. P. Manns, E. Schrumpf, K. M. Boberg and S. Schreiber: Genome-wide association analysis in primary sclerosing cholangitis. Gastroenterology 138, 1102-1111 (2010)
29. G. M. Hirschfield, X. Liu, C. Xu, Y. Lu, G. Xie, Y. Lu, X. Gu, E. J. Walker, K. Jing, B. D. Juran, A. L. Mason, R. P. Myers, K. M. Peltekian, C. N. Ghent, C. Coltescu, E. J. Atkinson, E. J. Heathcote, K. N. Lazaridis, C. I. Amos and K. A. Siminovitch: Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med 360, 2544-2555 (2009)
30. L. Franke, B. H. van, L. Fokkens, E. D. de Jong, M. Egmont-Petersen and C. Wijmenga: Reconstruction of a functional human gene network, with an application for prioritizing positional candidate genes. Am J Hum Genet 78, 1011-1025 (2006) (Pubitemid 43787692)
31. S. Banerjee, C. Owen and S. Chopra: Sickle cell hepatopathy. Hepatology 33, 1021-1028 (2001) (Pubitemid 32378197)
32. S. Aerts, D. Lambrechts, S. Maity, L. P. Van, B. Coessens, S. F. De, L. C. Tranchevent, M. B. De, P. Marynen, B. Hassan, P. Carmeliet and Y. Moreau: Gene prioritization through genomic data fusion. Nat Biotechnol 24, 537-544 (2006)
33. X. Wang, L. Zhang, R. Q. Ou, J. Wang, S. Y. Liu, Q. Chen and P. C. Su: [Association between CYP1A1 gene polymorphism and intrahepatic cholestasis of pregnancy]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 25, 70-72 (2008) (Pubitemid 351796753)
34. L. Zhang, S. Y. Liu, Q. Chen, Q. Y. Shi, H. Zou and L. Wu: [Association between polymorphisms of CYP17 and CYP3A4 genes and intrahepatic cholestasis of pregnancy in Chengdu]. Sichuan Da Xue Xue Bao Yi Xue Ban 37, 551-3, 582 (2006) (Pubitemid 44155436)
35. P. Fickert, T. Moustafa and M. Trauner: Primary sclerosing cholangitis-the arteriosclerosis of the bile duct? Lipids Health Dis 6, 3 (2007)
36. M. Arreseand S. J. Karpen: Nuclear receptors, inflammation, and liver disease: insights for cholestatic and fatty liver diseases. Clin Pharmacol Ther 87, 473-478 (2010)
37. G. Zollnerand M. Trauner: Nuclear receptors as therapeutic targets in cholestatic liver diseases. Br J Pharmacol 156, 7-27 (2009)
38. J. Chen, E. E. Bardes, B. J. Aronow and A. G. Jegga: ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res 37, W305-W311 (2009)
39. G. Sauter, F. Berr, U. Beuers, S. Fischer and G. Paumgartner: Serum concentrations of 7alpha-hydroxy-4-cholesten-3-one reflect bile acid synthesis in humans. Hepatology 24, 123-126 (1996) (Pubitemid 26249423)
40. C. Braconi, N. Huang and T. Patel: MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes. Hepatology 51, 881-890 (2010)
41. K. Said, H. Glaumann and A. Bergquist: Gallbladder disease in patients with primary sclerosing cholangitis. J Hepatol 48, 598-605 (2008)
42. D. J. Brandt, R. L. MacCarty, J. W. Charboneau, N. F. LaRusso, R. H. Wiesner and J. Ludwig: Gallbladder disease in patients with primary sclerosing cholangitis. AJR Am J Roentgenol 150, 571-574 (1988) (Pubitemid 18075395)
43. J. A. Summerfield, E. Elias, G. D. Hungerford, V. L. Nikapota, R. Dick and S. Sherlock: The biliary system in primary biliary cirrhosis. A study by endoscopic retrograde cholangiopancreatography. Gastroenterology 70, 240-243 (1976)
44. A. Ropponen, R. Sund, S. Riikonen, O. Ylikorkala and K. Aittomaki: Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population-based study. Hepatology 43, 723-728 (2006)
45. Y. Popov, E. Patsenker, P. Fickert, M. Trauner and D. Schuppan: Mdr2 (Abcb4)-/-mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro-and antifibrogenic genes. J Hepatol 43, 1045-1054 (2005) (Pubitemid 41627991)
46. K. E. Nakken, S. Nygard, T. K. Haaland, K. E. Berge, A. Odegaard, K. J. Labori and M. G. Raeder: Gene expression profiles reflect sclerosing cholangitis activity in abcb4 (-/-) mice. Scand J Gastroenterol 44, 211-218 (2009)
47. O. Rosmorduc, B. Hermelin, P. Y. Boelle, R. Parc, J. Taboury and R. Poupon: ABCB4 gene mutation-associated cholelithiasis in adults. Gastroenterology 125, 452-459 (2003) (Pubitemid 36929427)
48. J. F. Lucena, J. I. Herrero, J. Quiroga, B. Sangro, J. Garcia-Foncillas, N. Zabalegui, J. Sola, M. Herraiz, J. F. Medina and J. Prieto: A multidrug resistance 3 gene mutation causing cholelithiasis, cholestasis of pregnancy, and adulthood biliary cirrhosis. Gastroenterology 124, 1037-1042 (2003) (Pubitemid 36389806)
49. E. Jacquemin, J. M. De Vree, D. Cresteil, E. M. Sokal, E. Sturm, M. Dumont, G. L. Scheffer, M. Paul, M. Burdelski, P. J. Bosma, O. Bernard, M. Hadchouel and R. P. Elferink: The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. Gastroenterology 120, 1448-1458 (2001) (Pubitemid 32322319)
50. A. Floreani, I. Carderi, D. Paternoster, G. Soardo, F. Azzaroli, W. Esposito, A. Variola, A. M. Tommasi, D. Marchesoni, C. Braghin and G. Mazzella: Intrahepatic cholestasis of pregnancy: three novel MDR3 gene mutations. Aliment Pharmacol Ther 23, 1649-1653 (2006) (Pubitemid 43727475)
51. E. Jacquemin, D. Cresteil, S. Manouvrier, O. Boute and M. Hadchouel: Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy. Lancet 353, 210-211 (1999) (Pubitemid 29088042)
52. M. L. Eloranta, T. Hakli, M. Hiltunen, S. Helisalmi, K. Punnonen and S. Heinonen: Association of single nucleotide polymorphisms of the bile salt export pump gene with intrahepatic cholestasis of pregnancy. Scand J Gastroenterol 38, 648-652 (2003) (Pubitemid 36724045)
53. R. Mullenbach, K. J. Linton, S. Wiltshire, N. Weerasekera, J. Chambers, E. Elias, C. F. Higgins, D. G. Johnston, M. I. McCarthy and C. Williamson: ABCB4 gene sequence variation in women with intrahepatic cholestasis of pregnancy. J Med Genet 40, e70 (2003)
54. M. L. Eloranta, J. T. Heiskanen, M. J. Hiltunen, A. J. Mannermaa, K. R. Punnonen and S. T. Heinonen: Multidrug resistance 3 gene mutation 1712delT and estrogen receptor alpha gene polymorphisms in Finnish women with obstetric cholestasis. Eur J Obstet Gynecol Reprod Biol 105, 132-135 (2002)
55. A. Floreani, I. Carderi, D. Paternoster, G. Soardo, F. Azzaroli, W. Esposito, A. Variola, A. M. Tommasi, D. Marchesoni, C. Braghin and G. Mazzella: Intrahepatic cholestasis of pregnancy: three novel MDR3 gene mutations. Aliment Pharmacol Ther 23, 1649-1653 (2006) (Pubitemid 43727475)
56. R. Mullenbach, A. Bennett, N. Tetlow, N. Patel, G. Hamilton, F. Cheng, J. Chambers, R. Howard, S. D. Taylor-Robinson and C. Williamson: ATP8B1 mutations in British cases with intrahepatic cholestasis of pregnancy. Gut 54, 829-834 (2005) (Pubitemid 40732102)
57. J. G. Mella, E. Roschmann, J. C. Glasinovic, A. Alvarado, M. Scrivanti and B. A. Volk: Exploring the genetic role of the HLA-DPB1 locus in Chileans with intrahepatic cholestasis of pregnancy. J Hepatol 24, 320-323 (1996) (Pubitemid 26106130)
58. M. L. Eloranta, J. Heiskanen, M. Hiltunen, S. Helisalmi, A. Mannermaa and S. Heinonen: Apolipoprotein E alleles in women with intrahepatic cholestasis of pregnancy. Scand J Gastroenterol 35, 966-968 (2000)
59. J. Laasanen, S. Helisalmi, S. Iivonen, M. L. Eloranta, M. Hiltunen and S. Heinonen: Gamma 2 actin gene (enteric type) polymorphism is not associated with obstetric cholestasis or preeclampsia. Fetal Diagn Ther 23, 36-40 (2008) (Pubitemid 350249093)
60. R. Poupon, C. Ping, Y. Chretien, C. Corpechot, O. Chazouilleres, T. Simon, S. C. Heath, F. Matsuda, R. E. Poupon, C. Housset and V. Barbu: Genetic factors of susceptibility and of severity in primary biliary cirrhosis. J Hepatol 49, 1038-1045 (2008)
61. P. Invernizzi, C. Selmi, F. Poli, S. Frison, A. Floreani, D. Alvaro, P. Almasio, F. Rosina, M. Marzioni, L. Fabris, L. Muratori, L. Qi, M. F. Seldin, M. E. Gershwin and M. Podda: Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. Hepatology 48, 1906-1912 (2008)
62. G. M. Hirschfield, X. Liu, C. Xu, Y. Lu, G. Xie, Y. Lu, X. Gu, E. J. Walker, K. Jing, B. D. Juran, A. L. Mason, R. P. Myers, K. M. Peltekian, C. N. Ghent, C. Coltescu, E. J. Atkinson, E. J. Heathcote, K. N. Lazaridis, C. I. Amos and K. A. Siminovitch: Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med 360, 2544-2555 (2009)
63. X. Liu, P. Invernizzi, Y. Lu, R. Kosoy, Y. Lu, I. Bianchi, M. Podda, C. Xu, G. Xie, F. Macciardi, C. Selmi, S. Lupoli, R. Shigeta, M. Ransom, A. Lleo, A. T. Lee, A. L. Mason, R. P. Myers, K. M. Peltekian, C. N. Ghent, F. Bernuzzi, M. Zuin, F. Rosina, E. Borghesio, A. Floreani, R. Lazzari, G. Niro, A. Andriulli, L. Muratori, P. Muratori, P. L. Almasio, P. Andreone, M. Margotti, M. Brunetto, B. Coco, D. Alvaro, M. C. Bragazzi, F. Marra, A. Pisano, C. Rigamonti, M. Colombo, M. Marzioni, A. Benedetti, L. Fabris, M. Strazzabosco, P. Portincasa, V. O. Palmieri, C. Tiribelli, L. Croce, S. Bruno, S. Rossi, M. Vinci, C. Prisco, A. Mattalia, P. Toniutto, A. Picciotto, A. Galli, C. Ferrari, S. Colombo, G. Casella, L. Morini, N. Caporaso, A. Colli, G. Spinzi, R. Montanari, P. K. Gregersen, E. J. Heathcote, G. M. Hirschfield, K. A. Siminovitch, C. I. Amos, M. E. Gershwin and M. F. Seldin: Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet 42, 658-660 (2010)
64. G. M. Hirschfield, X. Liu, Y. Han, I. P. Gorlov, Y. Lu, C. Xu, Y. Lu, W. Chen, B. D. Juran, C. Coltescu, A. L. Mason, P. Milkiewicz, R. P. Myers, J. A. Odin, V. A. Luketic, D. Speiciene, C. Vincent, C. Levy, P. K. Gregersen, J. Zhang, E. J. Heathcote, K. N. Lazaridis, C. I. Amos and K. A. Siminovitch: Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis. Nat Genet 42, 655-657 (2010)
65. Y. Ohishi, M. Nakamura, N. Iio, S. Higa, M. Inayoshi, Y. Aiba, A. Komori, K. Omagari, H. Ishibashi and K. Tsukamoto: Singlenucleotide polymorphism analysis of the multidrug resistance protein 3 gene for the detection of clinical progression in Japanese patients with primary biliary cirrhosis. Hepatology 48, 853-862 (2008)
66. A. Tanaka, S. Nezu, S. Uegaki, K. Kikuchi, A. Shibuya, H. Miyakawa, S. Takahashi, I. Bianchi, P. Zermiani, M. Podda, H. Ohira, P. Invernizzi and H. Takikawa: Vitamin D receptor polymorphisms are associated with increased susceptibility to primary biliary cirrhosis in Japanese and Italian populations. J Hepatol 50, 1202-1209 (2009)
67. L. P. Lakatos, E. Bajnok, D. Hegedus, T. Toth, P. Lakatos and F. Szalay: Vitamin D receptor, oestrogen receptor-alpha gene and interleukin-1 receptor antagonist gene polymorphisms in Hungarian patients with primary biliary cirrhosis. Eur J Gastroenterol Hepatol 14, 733-740 (2002) (Pubitemid 34753956)
68. T. H. Karlsen, K. M. Boberg, M. Vatn, A. Bergquist, J. Hampe, E. Schrumpf, E. Thorsby, S. Schreiber and B. A. Lie: Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis. Genes Immun 8, 275-278 (2007) (Pubitemid 46672059)
69. A. Spurkland, S. Saarinen, K. M. Boberg, S. Mitchell, U. Broome, L. Caballeria, E. Ciusani, R. Chapman, G. Ercilla, O. Fausa, I. Knutsen, A. Pares, F. Rosina, O. Olerup, E. Thorsby and E. Schrumpf: HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens 53, 459-469 (1999) (Pubitemid 29224484)
70. K. Wiencke, T. H. Karlsen, K. M. Boberg, E. Thorsby, E. Schrumpf, B. A. Lie and A. Spurkland: Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes. Tissue Antigens 69, 161-169 (2007) (Pubitemid 46174871)
71. X. Yang, S. N. Cullen, J. H. Li, R. W. Chapman and D. P. Jewell: Susceptibility to primary sclerosing cholangitis is associated with polymorphisms of intercellular adhesion molecule-1. J Hepatol 40, 375-379 (2004) (Pubitemid 38230835)
72. M. Trauner, P. Fickert and M. Wagner: MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes. Semin Liver Dis 27, 77-98 (2007)